Impact of Inhibitors and L2 Antibodies upon the Infectivity of Diverse Alpha and Beta Human Papillomavirus Types

by Kwak, Kihyuck, Jiang, Rosie, Wang, Joshua W., Jagu, Subhashini, Kirnbauer, Reinhard, Roden, Richard B. S.
Published 2014

Immunologic Control of Mus musculus Papillomavirus Type 1

by Wang, Joshua W., Jiang, Rosie, Peng, Shiwen, Chang, Yung-Nien, Hung, Chien-Fu, Roden, Richard B. S.
Published 2015

Multivalent Human Papillomavirus L1 DNA Vaccination Utilizing Electroporation

by Kwak, Kihyuck, Jiang, Rosie, Jagu, Subhashini, Wang, Joshua W., Wang, Chenguang, Christensen, Neil D., Roden, Richard B. S.
Published 2013

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells

by Peng, Shiwen, Song, Liwen, Knoff, Jayne, Wang, Joshua W, Chang, Yung-Nien, Hannaman, Drew, Wu, T-C, Alvarez, Ronald D, Roden, Richard BS, Hung, Chien-Fu
Published 2014

Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease

by Peng, Shiwen, Qiu, Jin, Yang, Andrew, Yang, Benjamin, Jeang, Jessica, Wang, Joshua W., Chang, Yung-Nien, Brayton, Cory, Roden, Richard B. S., Hung, Chien-Fu, Wu, T.-C.
Published 2016

Sequential Cisplatin Therapy and Vaccination with HPV16 E6E7L2 Fusion Protein in Saponin Adjuvant GPI-0100 for the Treatment of a Model HPV16+ Cancer

by Peng, Shiwen, Wang, Joshua W., Karanam, Balasubramanyam, Wang, Chenguang, Huh, Warner K., Alvarez, Ronald D., Pai, Sara I., Hung, Chien-fu, Wu, T. -C., Roden, Richard B. S.
Published 2015

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions

by Wang, Joshua W., Jagu, Subhashini, Wang, Chenguang, Kitchener, Henry C., Daayana, Sai, Stern, Peter L., Pang, Susana, Day, Patricia M., Huh, Warner K., Roden, Richard B. S.
Published 2014